Is it Beneficial to Add Pharmacotherapy to Cognitive-Behavioral Therapy When Treating Anxiety Disorders? A Meta-Analytic Review
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
In order to examine the benefit of adding pharmacotherapy to cognitive-behavioral therapy (CBT) for anxiety disorders, we searched for studies comparing CBT plus pharmacotherapy and CBT plus pill placebo for adults meeting DSM-III-R or DSM-IV diagnostic criteria for an anxiety disorder between the 1st available year and July 1, 2008. Of 874 studies that were initially considered, 11 studies were identified, representing 471 patients with post-acute completer data and 236 participants with follow-up completer data. CBT plus pharmacotherapy was generally more effective than CBT plus placebo at post-treatment for measures of anxiety disorder severity (Hedges’ g = 0.59, 95% confidence interval: 0.29–0.90) and treatment response (OR: 1.95, 95% confidence interval: 1.25–3.03), but not at 6-month follow-up. Despite the relatively small number of studies, the fail-safe N suggested that the results are reliable. The largest effect sizes at post-treatment were found for panic disorder and generalized anxiety disorder. No differences were observed between self-report and clinician-administered measures. The reported effect sizes linearly decreased with publication year. In sum, there is preliminary evidence to suggest that adding pharmacotherapy to CBT is a useful short-term treatment strategy at least for some of the anxiety disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712 · cited 2×
“Odds ratios for treatment response after acute treatment phase Note: OCD = Obsessive-Compulsive Disorder; GAD = Generalized Anxiety Disorder; PDA = Panic Disorder with Agoraphobia; PD = Panic Disorder; SAD = Social Anxiety Disorder; Y-BOCS = Yale Brown Obsessive-Compulsive Scale (Goodman et al., 1989); CGI-I = Clinica…”
BackgroundFixed-and random-effects models in meta-analysis.
Hedges, L. V., & Vevea, J. L. (1998) · Psychological Methods · doi:10.1037/1082-989x.3.4.486 · Cited by 2,977
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
Hoffman, S. G., & Smits, J. A. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0415 · Cited by 1,420
Self-citationMulticenter Collaborative Panic Disorder Severity Scale
Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., & Papp, L. A. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.11.1571 · Cited by 1,001 · cited 3×
“Effect size estimates (Hedges’ g) for primary continuous anxiety measures Note: OCD = Obsessive-Compulsive Disorder; GAD = Generalized Anxiety Disorder; PDA = Panic Disorder with Agoraphobia; PD = Panic Disorder; SAD = Social Anxiety Disorder; PDSS = Panic Disorder Severity Scale (Shear et al., 1997).”
BackgroundInfluentialBarlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
Abramowitz, J. S. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.1.44 · Cited by 490 · cited 2×
“…have either been limited to only one disorder or have generally employed more liberal inclusion criteria (Furukawa, Watanabe, & Churchill, 2006; Mitte, Noack, & Hautzinger, 2005; Abramowitz, 1997; Rodebaugh, Holaway, & Heimberg, 2004; Bandelow, Seidler-Brandler, Becker, Wedekind, & Ruther, 2007).”
MethodMarks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478
The treatment of social anxiety disorder
Rodebaugh, T. L., Holaway, R. M., & Heimberg, R. G. (2004) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.07.007 · Cited by 424
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“treatment has been shown to be superior to medication alone [657,658,692-694], but not to CBT alone [83,658, 692,694,695].”
BackgroundResultFrom Pavlov to PTSD: The extinction of conditioned fear in rodents, humans, and anxiety disorders
VanElzakker, M. B., Kathryn Dahlgren, M., Caroline Davis, F., Dubois, S., & Shin, L. M. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.11.014 · Cited by 482
Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2014) · World Psychiatry · doi:10.1002/wps.20089 · Cited by 424
Mataix-Cols, D., Fernández de la Cruz, L., Monzani, B., Rosenfield, D., Andersson, E., Pérez-Vigil, A., Frumento, P., de Kleine, R. A., Difede, J., Dunlop, B. W., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3955 · Cited by 288
Self-citationMoving to Beat Anxiety: Epidemiology and Therapeutic Issues with Physical Activity for Anxiety
Kandola, A., Vancampfort, D., Herring, M., Rebar, A., Hallgren, M., Firth, J., & Stubbs, B. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0923-x · Cited by 291
Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
“In contrast, two meta-analyses (Bandelow et al., 2007; Hofmann et al., 2009) concluded that the combination of medication and CBT was better than CBT, and one RCT (van Apeldoorn et al., 2008) found medication equally effective as the combination, suggesting that medication contributed the greater…”
BackgroundMethodResultInfluentialCognitive-Behavioral Treatments for Anxiety and Stress-Related Disorders
Curtiss, J. E., Levine, D. S., Ander, I., & Baker, A. W. (2021) · Focus · doi:10.1176/appi.focus.20200045 · Cited by 144
Wolitzky-Taylor, K., Zimmermann, M., Arch, J. J., De Guzman, E., & Lagomasino, I. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.06.010 · Cited by 104
Orexins and fear: Implications for the treatment of anxiety disorders
Flores, Á., Saravia, R., Maldonado, R., & Berrendero, F. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.06.005 · Cited by 102
Enhancement of psychosocial treatment with D-cycloserine: Models, moderators, and future directions
Otto, M. W., Kredlow, M. A., Smits, J. A. J., Hofmann, S. G., Tolin, D. F., de Kleine, R. A., van Minnen, A., Evins, A. E., & Pollack, M. H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.007 · Cited by 70
“Decades of effort have been applied to examine the benefit of combining pharmacotherapy and cognitive-behavior therapy for anxiety disorders, and, as meta-analytic reviews attest, the result has often been disappointing – with limited acute advantages that are often lost over follow-up intervals (22-24).”
BackgroundSelf-citationVollbehr, N. K., Bartels-Velthuis, A. A., Nauta, M. H., Castelein, S., Steenhuis, L. A., Hoenders, H. J. R., & Ostafin, B. D. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204925 · Cited by 69
Wolitzky-Taylor, K., Fenwick, K., Lengnick-Hall, R., Grossman, J., Bearman, S. K., Arch, J., Miranda, J., & Chung, B. (2018) · Community Mental Health Journal · doi:10.1007/s10597-018-0252-x · Cited by 62
“, SSRIs) in the short-term and are larger in the long-term (Hofmann et al. 2009).”
Backgroundd-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
Hofmann, S. G., Wu, J. Q., & Boettcher, H. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-11 · Cited by 59
“, CBT plus pharmacotherapy) with CBT plus placebo across the anxiety disorders [9].”
MethodSelf-citationBarton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014) · Health Technology Assessment · doi:10.3310/hta18500 · Cited by 36
Tolin, D. F. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.08.007 · Cited by 25
Xie, Z.-J., Han, N., Law, S., Li, Z.-W., Chen, S.-Y., Xiao, J.-P., Zhang, Y., Gao, B.-L., Jiang, S.-S., Gao, H.-M., et al. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.32 · Cited by 10
Roberts, C. L., Farrell, L. J., Waters, A. M., Oar, E. L., & Ollendick, T. H. (2016) · Child Psychiatry & Human Development · doi:10.1007/s10578-015-0579-2 · Cited by 8
Can fMRI be used to predict the course of treatment for social anxiety disorder?
Hofmann, S. G. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.152 · Cited by 7
Self-citationMatsumoto, K., Hamatani, S., Makino, T., Uemura, T., Suzuki, F., Shinno, S., Ikai, T., Hayashi, H., Sutoh, C., & Shimizu, E. (2020) · JMIR Research Protocols · doi:10.2196/18216 · Cited by 7
New pharmacological strategies for augmenting extinction learning in anxiety disorders
Sartori, S. B., & Singewald, N. (2017) · e-Neuroforum · doi:10.1515/nf-2017-a011 · Cited by 3
A Comparison between Psychosocial and Pharmacological Treatments
Powers, M. B., Kauffman, B. Y., Diamond, A., & Smits, J. A. J. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00026-1 · Cited by 3
Self-citation
Metadata
- Authors
- Hofmann, S. G., Sawyer, A. T., Korte, K. J., & Smits, J. A. J.
- Venue
- International Journal of Cognitive Therapy
- Published
- 2009-06
- Volume
- 2
- Issue
- 2
- Pages
- 160-175
- ISSN
- 1937-1209 (ISSN-L)
- OpenAlex
- W2128055341
- Cited by
- 109
- References
- 14
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.